See More Hear More Watch More Hear More Get on iTunes
WSJ Daily Minute WSJMinute

Sun Pharma to buy Ranbaxy in $3bn deal

India’s Sun Pharmaceutical is taking over domestic rival Ranbaxy Laboratories from its Japanese owner, which struggled for years to turn around the company, in a deal valued at just over three billion dollars.


More from